600436 Stock Overview
Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
Zhangzhou Pientzehuang Pharmaceutical., Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥220.50 |
| 52 Week High | CN¥284.34 |
| 52 Week Low | CN¥180.69 |
| Beta | 0.78 |
| 1 Month Change | -10.76% |
| 3 Month Change | 9.70% |
| 1 Year Change | -6.43% |
| 3 Year Change | -54.04% |
| 5 Year Change | 103.90% |
| Change since IPO | 6,533.89% |
Recent News & Updates
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Share Price Could Signal Some Risk
Nov 25
These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely
Nov 07Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Oct 22Recent updates
Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Share Price Could Signal Some Risk
Nov 25These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely
Nov 07Earnings Beat: Zhangzhou Pientzehuang Pharmaceutical., Ltd Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Oct 22Estimating The Intrinsic Value Of Zhangzhou Pientzehuang Pharmaceutical., Ltd (SHSE:600436)
Sep 08Earnings Miss: Zhangzhou Pientzehuang Pharmaceutical., Ltd Missed EPS By 39% And Analysts Are Revising Their Forecasts
Aug 20Subdued Growth No Barrier To Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Price
Jul 12These 4 Measures Indicate That Zhangzhou Pientzehuang Pharmaceutical (SHSE:600436) Is Using Debt Safely
May 27Zhangzhou Pientzehuang Pharmaceutical., Ltd's (SHSE:600436) Business Is Yet to Catch Up With Its Share Price
Feb 28Shareholder Returns
| 600436 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.3% | -4.3% | -3.5% |
| 1Y | -6.4% | -3.4% | 10.9% |
Return vs Industry: 600436 underperformed the CN Pharmaceuticals industry which returned -3.4% over the past year.
Return vs Market: 600436 underperformed the CN Market which returned 10.9% over the past year.
Price Volatility
| 600436 volatility | |
|---|---|
| 600436 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600436 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600436's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 2,789 | Jin Ming Huang | www.zzpzh.com.cn |
Zhangzhou Pientzehuang Pharmaceutical., Ltd engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally. Its products include Chinese herbal decoction pieces, health foods, beverages, medical equipment, tonics, Chinese herbal medicine slices, cosmetics, and daily chemical products. The company was founded in 1956 and is based in Zhangzhou, China.
Zhangzhou Pientzehuang Pharmaceutical., Ltd Fundamentals Summary
| 600436 fundamental statistics | |
|---|---|
| Market cap | CN¥133.38b |
| Earnings (TTM) | CN¥3.08b |
| Revenue (TTM) | CN¥10.91b |
43.2x
P/E Ratio12.2x
P/S RatioIs 600436 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600436 income statement (TTM) | |
|---|---|
| Revenue | CN¥10.91b |
| Cost of Revenue | CN¥6.06b |
| Gross Profit | CN¥4.85b |
| Other Expenses | CN¥1.77b |
| Earnings | CN¥3.08b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.10 |
| Gross Margin | 44.49% |
| Net Profit Margin | 28.23% |
| Debt/Equity Ratio | 7.3% |
How did 600436 perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield45%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 16:27 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zhangzhou Pientzehuang Pharmaceutical., Ltd is covered by 31 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhi Xue Diao | Avic Securities Co., Ltd |
| Sandra Sun | BofA Global Research |
| Siti Bte Salikin | CFRA Equity Research |